AI Transforming Drug Discovery: Next Biotech Boom Ahead
Artificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
Review year-by-year annual performance for index funds to uncover patterns that inform proactive asset allocation.
25,727 articlesArtificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
Markets are digesting a potential shift in Fed communication as Kevin Warsh signals a move away from scripted guidanc...
The United States still holds a 714-million-barrel strategic reserve capacity, a focal point for policy debates and e...
Bitcoin reserves on centralized venues remain a sizable market feature even after FTX. Analysts say liquidity, lendin...
Three years can change a company’s story. Explore the signals that will determine MercadoLibre's path, focusing on fi...
A Wharton analysis finds Social Security dampens wealth inequality, but solvency risks and policy changes could erode...
The White House accelerates its plan to replace lost tariff revenue after a Supreme Court ruling, signaling a long, c...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
Tesla stock slides as delivery fears collide with SpaceX IPO chatter and a Cybercab roadmap, leaving investors weighi...
Wells Fargo lifts its NVIDIA price target to $315 ahead of the May earnings release, maintaining an Overweight rating...
Yorkville America pulled Truth Social crypto ETF filings, signaling a pivot to the 40 Act structure. Analysts debate ...
In 2026, workers using AI are finishing tasks faster, but broad productivity data remains subdued. Economists compare...